Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Green Coffee Supplementation on Inflammatory Biomarkers in Obese Patients With Metabolic Syndrome

NCT05688917 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT05688917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Green Coffee Supplementation on Inflammatory Biomarkers in Obese Patients With Metabolic Syndrome
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
September 3, 2020
Completion date
September 30, 2022
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, metabolic syndrome, obesity, supportive care